Research Topics
Species | Hassan IzzedineSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional studyJohann Cailhol
Infectious and Tropical Diseases Department, Avicenne Hospital APHP and Paris 13 University, 125 route de Stalingrad, 93009, Bobigny, France
BMC Nephrol 12:40. 2011..Since little is known about chronic kidney disease (CKD) among people living with HIV/AIDS (PLWHA) in Sub-Saharan Africa, the prevalence and nature of CKD were assessed in Burundi through a multicenter cross-sectional study...
Sunitinib malateHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital 83, Blvd de l Hopital, 75013 Paris, France
Cancer Chemother Pharmacol 60:357-64. 2007..The present article reviews the recent pharmacologic and clinical data related to the use of this new promising drug in the field of oncology...
Oculorenal manifestations in systemic autoimmune diseasesHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 43:209-22. 2004..Examination of the eye and kidney should be performed routinely in those diseases. This article reviews the major types of oculorenal manifestations in systemic autoimmune diseases...
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studiesHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Kidney Int 66:1153-8. 2004..We report a complete analysis on the renal tolerance of ADV at the currently approved dose of 10 mg daily for the treatment of chronic hepatitis B...
Loss of podocyte dysferlin expression is associated with minimal change nephropathyHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 48:143-50. 2006..We therefore suggest that dysferlin is present in glomeruli and may be associated with glomerular permeability...
Antiretroviral and immunosuppressive drug-drug interactions: an updateHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Kidney Int 66:532-41. 2004....
Oculo-renal disorders in infectious diseasesHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Int Ophthalmol 25:299-319. 2004..The aim of this article is to review the potential ocular and renal disorders in infectious diseases to which humans are susceptible and to determine prevalence of these diseases...
Antiretroviral drugs and the kidney: dosage adjustment and renal toleranceHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Curr Pharm Des 10:4071-9. 2004..6 to 1%). Therefore, administration of antiretroviral drugs in human immunodeficiency virus (HIV) patients with nephropathy is not uncommon...
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, 47 83 boulevard de l Hopital, 75013 Paris, France
Nephrol Dial Transplant 20:743-6. 2005..However, controlled data are sparse on the long-term renal tolerability of TDF at the currently approved daily dose of 300 mg in treatment-naive HIV-infected patients...
Abnormal blood pressure circadian rhythm: a target organ damage?Hassane Izzedine
Nephrology Department, Pitie Salpetriere Hospital, 47 83, Blvd de l Hopital, 75013, Paris, France
Int J Cardiol 107:343-9. 2006..These data suggest that patients in whom blood pressure decreases during the night incur less damage to their brain, kidneys, heart, and blood vessels than people with elevated nocturnal BP...
Gastric bypass and resolution of proteinuria in an obese diabetic patientH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Diabet Med 22:1761-2. 2005..The reduction of glomerular hyperfiltration and blood pressure associated with the important weight loss may be the major contributors to the decrease of proteinuria and serum creatinine levels in our patient...
Is low-dose methotrexate nephrotoxic? Case report and review of the literatureH Izzedine
Department of Nephrology, 83, Blvd de l Hopital, Pitie Salpetriere Hospital, 75013 Paris, France
Clin Nephrol 64:315-9. 2005..We suggest that patients on low-dose MTX therapy even alone, should be periodically monitored for creatinine levels...
Drug-induced glomerulopathiesHassan Izzedine
Pitie Salpetriere Hospital, Department of Nephrology, 47 83 boulevard de l Hopital, 75013 Paris, France
Expert Opin Drug Saf 5:95-106. 2006..This is, for instance, reflected in the fact that patients with drug-induced nephritic syndrome frequently have the HLA-B8 and DR3 antigens. In depth information is provided for the previously mentioned disorders...
Renal effects of PPARalpha-agonistsH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Minerva Urol Nefrol 56:339-42. 2004..While they are mainly used as hypolipidemic agents, PPARalpha agonists may also be postulated to exhibit renoprotective effects. This review summarizes current knowledge regarding the effects of PPARalpha agonists on the kidney...
Drug-induced diabetes mellitusHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Expert Opin Drug Saf 4:1097-109. 2005..To review the medications that influence glucose metabolism with a focus on hypertensive, transplant and HIV-infected patient populations...
Antiviral drug-induced nephrotoxicityHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 45:804-17. 2005..In this article, we review the pathogenesis of antiviral drug-induced kidney injury, common nephrotoxic renal syndromes, and strategies for preventing kidney injury...
PPAR-gamma-agonists' renal effectsH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Minerva Urol Nefrol 57:247-60. 2005..These renal protective effects of PPAR-gamma agonists suggest that they may provide a novel intervention strategy to prevent vascular and glomerular sclerosis...
Chronic calcifying pancreatitis and systemic lupus erythematousHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Pancreas 31:289-90. 2005..We report the case of a 59-year-old white woman with a history of mechanic aortic valve replacement and SLE presented to the emergency unit for acute pancreatitis with no other identifiable etiology...
Antiviral drug-induced kidney and electrolytes disordersH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Minerva Urol Nefrol 55:157-72. 2003..This article reviews the incidence, presentation, prevention and management of antiviral drug-induced renal dysfunction...
[How and when to search for a renal artery atheromatous stenosis in diabetic patients?]H Izzedine
Service de Nephrologie, Groupe Hospitalier de la Pitié Salpêtrière, Paris
Diabetes Metab 28:244-9. 2002..There are several specific criteria, that may confirm the suspicion of a RAAS. Renal arteriography is still the goal standard for diagnosing renal artery stenosis...
Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literatureHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Clin Pharmacol Ther 71:503-7. 2002..Severe symptomatic hyponatremia induced by the syndrome of inappropriate secretion of antidiuretic hormone should be considered a rare but possible complication associated with ACE inhibitor therapy...
Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD)H Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Minerva Urol Nefrol 54:93-106. 2002....
Renal function after aortic stent-grafting including coverage of renal arterial ostiaHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 39:730-6. 2002..Renal function was stable in all patients at 30 months' follow-up. We suggest that renal function is unaffected by coverage of renal arterial ostia with Gianturco Z stents...
Kidney diseases in HIV/HCV-co-infected patientsHassane Izzedine
Departments of Nephrology, Pitie Salpetriere Hospital, Paris, France
AIDS 23:1219-26. 2009..Hepatitis C virus (HCV) co-infection occurs in 25% of HIV-infected persons. The impact of HIV/HCV coinfection on renal and patient outcomes is unclear...
An appraisal of antiretroviral drugs in hemodialysisH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Kidney Int 60:821-30. 2001..Therefore, the administration of antiretroviral drugs in human immunodeficiency virus (HIV) patients with nephropathy is not uncommon...
Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal functionH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, 47 83 Bd de l Hopital, F 75013 Paris, France
Nephron 89:62-7. 2001..Abacavir is a potent, novel 2'-deoxyguanosine analogue reverse transcriptase inhibitor (NRTI) which effectively suppresses HIV-1 replication. To date, there is no pharmacokinetic study in patients with renal impairment...
Retinopathy, hematuria, and diabetic nephropathyH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Nephron 88:382-3. 2001..We suggest from our retrospective analysis that renal-retinal diabetic syndrome really exists...
Electrolyte disorders related to EGFR-targeting drugsHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Crit Rev Oncol Hematol 73:213-9. 2010..This is explained by elective tubular expression of renal EGF/EGFR. In this paper, we focus on electrolyte disorders related to anti-EGFR treatment and discuss the tubular involvement of these drugs based on their renal expression...
Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic studyH Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Nephrol 21:162-4. 2001..48 h after interrupting treatment, she recovered normal neurological status and 500 mg of valacyclovir every 2 days was effective and well tolerated...
Drug-induced Fanconi's syndromeHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 41:292-309. 2003..Acquired renal tubular defects resulting in FS also have been described in association with many exogenous agents, whether administered or accidentally ingested. This review concentrates on drug-induced FS...
Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapyHassane Izzedine
Department of Nephrology, , Paris, France
Nephron 92:944-6. 2002
Temsirolimus-induced glomerulopathyHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Oncology 76:170-2. 2009..Kidney biopsy revealed ischemic glomeruli and focal segmental glomerulosclerosis lesion. Proteinuria level decreased to 2.80 g per day two weeks after temsirolimus withdrawal. Clinicians should be aware to this complication...
Eye and kidney: from clinical findings to genetic explanationsHassane Izzedine
Nephrology and Ophthalmology Departments, Pitie-Salpetriere Hospital, Paris, France
J Am Soc Nephrol 14:516-29. 2003
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIVHeidi Hannon
Nephrology Department, , Paris, France
Nephrol Dial Transplant 19:386-90. 2004..CONCLUSIONS: Our study shows that ADV dosed at 10 mg/day for the treatment of LAM-resistant chronic hepatitis B in patients co-infected with HIV is not associated with renal tubular dysfunction or a significant change in renal function...
[Anticancer drug-induced nephrotoxicity]Corinne Isnard-Bagnis
Service de Nephrologie, Hopital Pitie Salpetriere, 83, Boulevard de l Hopital, 75013 Paris, France
Nephrol Ther 1:101-14. 2005....
Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disordersBenjamin Terrier
Department of Internal Medicine, Groupe Hospitalier Pitie Salpetriere, Universite Pierre et Marie Curie, Paris, France
Nephrol Dial Transplant 26:3577-81. 2011..In patients with end-stage renal disease, thromboses are common. However, the implication of CryoFg was never assessed. The aim of this study is to describe the prevalence and the significance of CryoFg in patients with renal disorders...
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS studyStephanie Dominguez
Département des Maladies Infectieuses et Tropicales INSERM U720, CHU Pitie Salpetriere, Paris, France
J Med Virol 79:105-10. 2007..This add-on pilot study supports the concept of double dose tenofovir to virologically overcome the decreased sensitivity of NRTI-resistant viruses. However, the safety of this regimen needs to be considered carefully...
[Is dialysis efficient in the prevention of ionic contrast agent-induced nephropathy?]Svetlana Karie
Service de Nephrologie, Groupe hospitalier Pitié Salpêtrière 83, boulevard de I hôpital, 75013 Paris, France
Presse Med 34:803-8. 2005..No data yet justify a conclusion that a hemodialysis session immediately after injection of a CM in chronic dialysis patients might be helpful...
Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART eraCorinne Isnard Bagnis
Department of Nephrology, Pitie Salpetriere Hospital, AP HP and CERVI, Paris, France
Nephron Physiol 103:p131-8. 2006..HIV-infected patients may develop a variety of underreported metabolic abnormalities that may be classified into HIVAN, specific HIV abnormalities, coincidental renal disorders and anti-retroviral-treatment-induced side effects...
Renal safety of tenofovir in HIV treatment-experienced patientsHassane Izzedine
Department of Nephrology, , Paris, France
AIDS 18:1074-6. 2004..Proximal tubulopathy was diagnosed 6.89 +/- 5.51 months after TDF therapy started. All abnormalities normalized within 4.7 +/- 2.94 weeks after drug discontinuation...
FHD: an index to evaluate drug elimination by hemodialysisVincent Launay-Vacher
Department of Nephrology, , Paris, France
Am J Nephrol 25:342-51. 2005..F(HD )could be the index of choice to determine when to administer a drug, before or after the session, in hemodialysis patients...
[Angiogenesis inhibitor therapies: focus on hypertension and kidney toxicity]Hassan Izzedine
Service de Nephrologie, Hopital Pitie Salpetriere, 83, Boulevard de l Hopital, 75013 Paris, France
Bull Cancer 94:981-6. 2007..Anti-angiogenic drugs recently marketed or still under clinical development, may interact with the kidneys. Clinical and pathological, and mechanisms of their renal toxicity are presented in this article...
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathyHassane Izzedine
Department of Nephrology, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Universite Pierre et Marie Curie Paris IV, 75013 Paris, France
J Infect Dis 194:1481-91. 2006..Tenofovir disoproxil fumarate (TDF) may induce renal proximal tubulopathy (rPT). There are no data on pharmacogenomic predictors of rPT in the genes encoding the multidrug-resistance protein (MRP) 2 and MRP4 transporters...
Renal tubular drug transportersVincent Launay-Vacher
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Nephron Physiol 103:p97-106. 2006..Detailed information concerning molecular and cellular aspects of drug transporters expressed in the kidney has facilitated studies of the mechanisms underlying renal disposition as well as transporter-mediated drug interactions...
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsVincent Launay-Vacher
Department of Nephrology, Pitié Salpetricre Hospital, Paris, France
Med Sci Monit 10:CR209-12. 2004..The high frequency of this disease in the general US population has been assessed in the NHANES III study. However, the frequency of chronic renal insufficiency among cancer patients remains unclear...
Pharmacokinetics of tenofovir in haemodialysisHassane Izzedine
Department of Nephrology, , Paris, France
Nephrol Dial Transplant 18:1931-3. 2003
Clinical review: use of vancomycin in haemodialysis patientsVincent Launay-Vacher
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Crit Care 6:313-6. 2002..The aim of the present review is to establish guidelines for handling this drug in such patients. We indicate how and when plasma concentrations of vancomycin should be determined in dialysis patients...
Detection of vascular access stenosis by measurement of access blood flow from ionic dialysanceLucile Mercadal
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Blood Purif 20:177-81. 2002..We evaluate the reliability of the measurement of Q(a) by this method in detecting significant access stenoses...
Ear and kidney syndromes: molecular versus clinical approachHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Kidney Int 65:369-85. 2004..Here, we describe ear and kidney clinical syndromes and their molecular expression...
Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failureVincent Launay-Vacher
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Clin Pharmacokinet 44:221-35. 2005..In the meantime, it could be generally advised to administer all antitubercular drugs after the haemodialysis session, even though some drugs are known to be non-dialysable...
Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adaptedVincent Launay-Vacher
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
J Pain 6:137-48. 2005..Perspective This well-known treatment strategy now adapted for use in patients with renal insufficiency should secure and rationalize pain treatment in those patients...
Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patientsVincent Launay-Vacher
Department of Nephrology, Pitie Salpetriere Hospital, 83, Boulevard de l Hopital, 75013 Paris, France
Int J Cardiol 101:9-17. 2005....
Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculationLucile Mercadal
Department of Nephrology, Hopital de la Pitie, 83 bd de l hopital, F 75013 Paris, France
Nephrol Dial Transplant 17:106-11. 2002..As it has been suggested that this discrepancy could be due to the cardiopulmonary recirculation, we studied the relationship between these two parameters in a particular dialysis setting without cardiopulmonary recirculation...
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy
Saint Antoine Hospital and University Pierre et Marie Curie VI, Paris, France
Crit Rev Oncol Hematol 80:369-79. 2011....
Renal involvement in Castleman diseaseKhalil El Karoui
Department of Pathology, Hopital Europeen Georges Pompidou, AP HP Universite Paris Descartes, Paris, France
Nephrol Dial Transplant 26:599-609. 2011..Renal involvement in CD has been described in only single-case reports, which have included various types of renal diseases...
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and managementHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Eur J Cancer 46:439-48. 2010..Periodic monitoring of urinary protein should be carried out in anti-VEGF-treated patients and patients showing proteinuria need special referral to nephrologists...
A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndromeHassane Izzedine
Department of Nephrology, La Pitie Salpetriere Hospital, 47 80 Boulevard de l Hôpital, Assistance Publique Hopitaux de Paris, Pierre et Marie Curie University, 75013 Paris, France
Nat Clin Pract Nephrol 4:110-4. 2008..However, 18 months after steroids were discontinued, renal function declined dramatically. Furthermore, the patient had CD8+ lymphocytosis as well as interstitial tissue infiltration by CD8+ T lymphocytes...
Lymphadenopathy and proteinuriaSvetlana Karie
Department of Nephrology, , Paris, France
Nephrol Dial Transplant 19:739-41. 2004
Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertensionHassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 50:203-18. 2007..This article reviews data relating to hypertension and proteinuria associated with the use of these drugs...
The nephrotoxic effects of HAARTHassane Izzedine
Department of Nephrology, La Pitie Salpetriere Hospital, Paris, France
Nat Rev Nephrol 5:563-73. 2009....
Primary chronic interstitial nephritis in Crohn's diseaseHassane Izzedine
Department of Nephrology, , and INSERM U423, Paris, France
Gastroenterology 123:1436-40. 2002..CONCLUSIONS: Several unanswered questions remain concerning the frequency of interstitial nephritis in patients with Crohn's disease, as well as the exact role of mesalamine in the development of chronic interstitial nephritis...
[Chyluria presenting as milky urine and nephrotic-range proteinuria and milky urine: chyluria or glomerulopathy? Case report and literature review]Caroline Poitou
Service de Nephrologie, Hopital de la Pitie Salpetriere, Paris, France
Nephrol Ther 5:642-7. 2009..Chyluria is one of the causes of post-nephronic nephrotic proteinuria. Depending on the impact of the chyluria for the patient, there will either be no treatment, or a treatment by sclerotherapy or surgery...
[Drug-induced nephrotoxicity: bibliography from January 2003 to December 2004]Svetlana Karie
Service de Nephrologie, Groupe Hospitalier Pitie Salpetriere, 83, Boulevard de l Hopital, 75015 Paris, France
Nephrol Ther 1:285-95. 2005..In this article, we present an updated version of the bibliography containing the case reports of nephrotoxicity published in the international literature from January 2003 to December 2004...
Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemiaHassane Izzedine
Department of Nephrology, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Pierre et Marie Curie University, Paris, France
Int J Hematol 89:218-22. 2009..A renal biopsy performed suggested the diagnosis of acute tubular necrosis. The diagnosis of ARF related to IgM flare after Rituximab therapy was made...
Hyponatraemic syndrome in a patient with tuberculosis--always the adrenals?Laurent Camous
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Nephrol Dial Transplant 23:393-5. 2008
Hyperpnoea and ketonuria in an HIV-infected patientC Roubaud-Baudron
Department of Nephrology, , , Assistance Publique-Hopitaux de Paris, Pierre et Marie Curie University, 75013 Paris, France
Nephrol Dial Transplant 22:649-51. 2007
[Drud-induced nephrotoxicity: Bibliography from January 2003 to December 2005]Svetlana Karie
ICAR, Service de Nephrologie, Groupe Hospitalier de la Pitié Salpêtrière, 83, Boulevard de l Hopital, 75015 Paris, France
Nephrol Ther 2:368-78. 2006..In this article, we present an updated version of the bibliography containing the case reports of nephrotoxicity published in the international literature from January 2003 to December 2005...
Why is a shrunken bladder and a nephrotic kidney an expression of the same disease?Sophie Georgin-Lavialle
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Nephrol Dial Transplant 19:3193-5. 2004
Nephrolithiasis with hypomagnesemia: what is the cause?Hassane Izzedine
Department of Nephrology, Pitie Salpetriere Hospital, Paris, France
Am J Kidney Dis 49:862-4. 2007
Atazanavir crystal nephropathyHassane Izzedine
AIDS 21:2357-8. 2007
Macrocytosis due to treatment with sunitinibBertrand Billemont
N Engl J Med 357:1351-2; author reply 1352. 2007
Post-transplantation proteinuria and sirolimusHassane Izzedine
N Engl J Med 353:2088-9. 2005
Acute renal failure in HIV patientsHassane Izzedine
Nephrol Dial Transplant 22:2757-62. 2007
Viral load and HIV-associated nephropathyHassane Izzedine
N Engl J Med 353:1072-4. 2005
Fanconi syndrome associated with didanosine therapyHassane Izzedine
AIDS 19:844-5. 2005
Renal tubular transporters and antiviral drugs: an updateHassane Izzedine
AIDS 19:455-62. 2005..Along with drug-metabolizing enzymes, these transporters are important determinants of drug effectiveness and toxicity. This review examines the role that these transporters play in renal disposition of antiviral drugs...
Immunosuppressive and calcimimetic drug-drug interactionsHassane Izzedine
Kidney Int 68:1903-4. 2005
HIV-2 infection and HIV-associated nephropathyHassane Izzedine
AIDS 20:949-50. 2006
Atazanavir: a novel inhibitor of HIV-protease in haemodialysisHassane Izzedine
Nephrol Dial Transplant 20:852-3. 2005
Using the right MDRD equationVincent Launay-Vacher
Kidney Int 66:2089; author reply 2089-90. 2004
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failureSvetlana Karie
Nephrol Dial Transplant 21:3606-8. 2006
Gemcitabine-induced thrombotic microangiopathy: a systematic reviewHassane Izzedine
Nephrol Dial Transplant 21:3038-45. 2006
Pharmacokinetics of tramadol in a hemodialysis patientHassane Izzedine
Nephron 92:755-6. 2002
Inadequacy of antiretroviral drugs dosage adjustment in HIV patients receiving dialysisHassane Izzedine
Kidney Int 64:2324. 2003
Thrombotic microangiopathy and anti-VEGF agentsHassane Izzedine
Nephrol Dial Transplant 22:1481-2. 2007
Interstitial nephritis in a patient taking sorafenibHassane Izzedine
Nephrol Dial Transplant 22:2411. 2007
Topiramate-induced renal tubular acidosisHassane Izzedine
Am J Med 116:281-2. 2004
Post-colonoscopy appendicitis: case report and review of the literatureHassane Izzedine
Am J Gastroenterol 100:2815-7. 2005
Lamivudine and HBV-associated nephropathyHassane Izzedine
Nephrol Dial Transplant 21:828-9. 2006
Probenecid-induced membranous nephropathyHassane Izzedine
Nephrol Dial Transplant 22:2405-6. 2007
